January 7th, 2023A genetic model for central chondrosarcoma evolution correlates with patient outcome William Cross 1, Iben Lyskjær 1 2, Tom Lesluyes 3, Steven Hargreaves 1, Anna-Christina Strobl 4, Christopher Davies 1 4, Sara Waise 3 5, Shadi Hames-Fathi 1,...

January 3rd, 2023Happy New Year! With the new year, the Chondrosarcoma Foundation is kicking-off the year by hosting and promoting Chondrosarcoma Awareness Day on February 6 (Shayna’s heavenly 32nd birthday). We ask that you join us in wearing a Yellow Ribbon or...

December 26th, 2022I would like to wish everyone the best for this holiday season. May you all cherish the moments you have with your family and blessings to you all for a Healthy and Happy New Year. I thank each and every one of you for the caring and support you...

December 17th, 2022With Chondrosarcoma Awareness Day: February 6, less than two months away, we want to share stories of our community / our family who provide us with inspiration. Some of our members lost their battle with Chondrosarcoma. Others are surviving,...

December 10th, 2022International Chondrosarcoma Awareness Day February 6, 2023 Wear A Yellow Ribbon / Wrist Band and Show Your Support for Chondrosarcoma Research and Clinical Trials As many of you are aware to honor my daughter who passed away from Grade 3...

November 28th, 2022

November 28th, 2022Inhibrx has initiated a phase 2 clinical trial to treat unresectable or metastatic conventional chondrosarcoma. The poster was presented at the Connective Tissue Oncology Society (CTOS) in Vancouver, Canada from November 16-19. The results of the...

November 23rd, 2022Inhibrx is recruiting for Chondrosarcoma patients to participate in their Phase 2 study of the medication. Presently there are 130 openings for the Phase 2 trial. Summary is listed below, for more...